Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who...

Full description

Bibliographic Details
Main Authors:	Giacomo Oteri, Giuseppina Campisi, Vera Panzarella, Ilaria Morreale, Riccardo Nucera, Olga Di Fede, Antonio Picone, Antonia Marcianò
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/4021952

Similar Items

Platelet-Rich Plasma (PRP) in Dental Extraction of Patients at Risk of Bisphosphonate-Related Osteonecrosis of the Jaws: A Two-Year Longitudinal Study
by: Rodolfo Mauceri, et al.
Published: (2020-06-01)

Serum biomarkers for antiresorptives-related osteonecrosis of the jaw: In vivo and clinical validation studies
by: Hye-Yeon Kim, et al.
Published: (2020-10-01)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association
by: Antonia Marcianò, et al.
Published: (2020-12-01)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019-11-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019-12-01)

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
by: Kununya Pimolbutr, et al.
Published: (2018-01-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
by: Olga Di Fede, et al.
Published: (2018-01-01)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
by: Roberto Sacco, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.
by: Takuma Watanabe, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
by: Watanabe, Takuma
Published: (2021)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
by: Giuseppina Campisi, et al.
Published: (2020-08-01)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
by: Julian Woolley, et al.
Published: (2021-01-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

Early Detection of Antiresorptive drug-Related Osteonecrosis of the Jaws (ARONJ) with Technetium-99m Methylene Diphosphonate-based Bone Scintigraphy
by: Anna Marie J. Miranda, et al.
Published: (2015)

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
by: Giuliano Ascani, et al.
Published: (2014-01-01)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
by: Masaki Minabe, et al.
Published: (2020-12-01)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
by: Camilla Ottesen, et al.
Published: (2020-04-01)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
by: Gianfranco Favia, et al.
Published: (2016-01-01)

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study
by: Rodolfo Mauceri, et al.
Published: (2018-01-01)

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols
by: Olga Di Fede, et al.
Published: (2021-08-01)

Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
by: Pramod S Sankar, et al.
Published: (2018-01-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Appropriateness in Dentistry: A Survey Discovers Improper Procedures in Oral Medicine and Surgery
by: Giacomo Oteri, et al.
Published: (2018-01-01)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
by: Heidi M. Ekholm, et al.
Published: (2021-08-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012-01-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Osteonecrosis of the jaw in association to bisphosphonates
by: Mattos, Ana Carolina Lopes
Published: (2020)

Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?
by: Renato Patrizio Costa, et al.
Published: (2019-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS
by: Rosen Tsolov, et al.
Published: (2020-10-01)

Expert opinion about osteonecrosis of the jaw
by: Jeong Keun Lee, DDS, PhD
Published: (2017-06-01)

Osteonecrosis of jaw associated with bisphosphonate use
by: Ashu Rastogi, et al.
Published: (2012-01-01)

Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013-01-01)

Corticosteroid-induced Knee Osteonecrosis and Accompanying Femoral Head Osteonecrosis
by: Nuran Sabir, et al.
Published: (2019-07-01)